Gsa Capital Partners LLP Caribou Biosciences, Inc. Transaction History
Gsa Capital Partners LLP
- $1.43 Billion
- Q2 2025
A detailed history of Gsa Capital Partners LLP transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 166,396 shares of CRBU stock, worth $479,220. This represents 0.01% of its overall portfolio holdings.
Number of Shares
166,396
Previous 17,605
845.16%
Holding current value
$479,220
Previous $16,000
1212.5%
% of portfolio
0.01%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CRBU
# of Institutions
134Shares Held
43.6MCall Options Held
25KPut Options Held
53.2K-
Black Rock Inc. New York, NY6.95MShares$20 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.09MShares$11.8 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.07MShares$8.84 Million0.46% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY2.27MShares$6.55 Million0.02% of portfolio
-
Pictet Asset Management Sa Geneva 73, V81.81MShares$5.21 Million0.01% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $175M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...